This Combined Synopsis/Solicitation opportunity from Department Of Defense was posted on July 7, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Immunization Supply FY2025, Medical Detachment (MEDDET) Guam Army National Guard (GUARNG)

Closed

W911YU25QA025Federal

Submission Closed07/10/2025, 03:00:00 AM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

Supplier of Red Sealing Compound (NSN 8030015650423)

Defense Logistics Agency

POSTED

DEADLINE

Supply of 4% Chlorhexidine Gluconate Surgical Detergent

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Isoniazid Tablet Manufacturing

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Tetrahydrozoline Hydrochloride Ophthalmic Solution Supplier

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Tolnaftate Powder, USP 1%

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0122

Solicitation SPE2DP-27-T-0122 is a procurement request by the Defense Logistics Agency for surgical detergent containing 4% chlorhexidine gluconate, identified by NSN 6505-01-101-3759. The requirement is for one 8 oz bottle to be delivered FOB Destination to the USNS ABLE TAGOS 20. The item is FDA regulated and must have a total shelf life of 24 months, with at least 21 months remaining upon delivery to the government. The original required delivery date is October 21, 2026, with a delivery lead time of 20 days after award. The contract mandates strict adherence to Medical Marking Standard No. 1C and DLA packaging requirements RP001. Packaging must be commercial, utilizing sealed unit containers and suitable exterior shipping containers. If the material is deemed hazardous per FED-STD-313, it must follow TQ requirement IP025; otherwise, it must comply with ASTM D3951. Offerors must submit quotes via DIBBS by October 26, 2026, and provide a Safety Data Sheet meeting 29 CFR 1910.1200(g) prior to award. The procurement is subject to destination inspection under FAR 52.246-2 and incorporates the Buy American Act and HUBZone price evaluation preferences. Invoicing and receiving reports must be processed through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

TETRAHYDROZOLINE HYDRO

Solicitation # SPE2DP-27-T-0130

Solicitation SPE2DP-27-T-0130 is a fixed-price contract issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Tetrahydrozoline Hydrochloride Ophthalmic Solution, USP (NSN 6505-00-139-4600). The requirement consists of one bottle of 0.05 percent, 15 ml solution, to be delivered FOB Destination to the Naval Med Readiness Logistics Cmd in Williamsburg, Virginia, with a required delivery date of October 21, 2026. The item is classified as a Type I (Code Q) item with a non-extendable shelf life of 36 months. The contract mandates strict adherence to commercial packaging standards, requiring sealed unit containers and exterior shipping containers that protect contents from damage. All materials must be marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and preservation must comply with MIL-STD-2073-1E and special packaging instructions MPWN00001. Additionally, the contractor must comply with FDA regulations, the Buy American and Balance of Payments Program, and specific hazardous material labeling requirements under 29 CFR 1910.1200. Inspection and acceptance will occur at the destination point. Invoicing and payment are to be processed electronically through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0126

Solicitation SPE2DP-27-T-0126 is a fixed-price procurement issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the supply of 15 bottles of Tolnaftate Powder, USP 1%, 45 GM (NSN 6505014807897). The contract requires delivery within 20 days after receipt of order, with an original required delivery date of October 21, 2026. The shipment is destined for the USS Lewis B Puller ESB 3, with both inspection and acceptance occurring at the destination. The item is classified as a Type I (Code Q) item with a non-extendable shelf life of 36 months. Compliance requirements include adherence to the DLA Master List of Technical and Quality Requirements, which takes precedence over ASTM D3951 for commercial packaging. All packaging must be marked and labeled according to MIL-STD-129 and Medical Marking Standard No. 1, with palletization following RP001 requirements. If the material is deemed hazardous per FED-STD-313, it must be packaged according to TQ requirement IP025. Administratively, the contract mandates the use of the Wide Area WorkFlow (WAWF) system for electronic invoicing and requires compliance with the Buy American and Balance of Payments Program, the Berry Amendment, and DFARS 252.204-7012 for safeguarding covered defense information.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

ENROFLOXACIN INJECTION

Solicitation # SPE2DP-27-T-0128

Solicitation SPE2DP-27-T-0128, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is for the procurement of six units of veterinary Enrofloxacin Injection. This FDA-regulated drug is an intramuscular solution for dogs, formulated at 2.27% (2.5mg/kg) in 20ML doses for managing bacterial pathogens. The item has a non-extendable shelf life of 24 months and requires specific storage conditions: protection from direct sunlight, no freezing, and maintenance at or below 25 degrees Celsius, with permitted excursions up to 40 degrees Celsius. Delivery is set for October 19, 2026, with FOB Destination terms. The shipping destination is the USA Med Mat Ctr EUR in Kaiserslautern, Germany. Packaging must be commercial and compliant with MIL-STD-2073-1E and DLA requirement RP001, while marking must strictly adhere to Medical Marking Standard No. 1, which supersedes MIL-STD-129. The contract incorporates various FAR and DFARS clauses, including those for safeguarding covered defense information, the Buy American Act, and the prohibition of covered defense telecommunications equipment. Invoicing and payment requests must be processed electronically via the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

CHARCOAL, ACTIVATED, SUS

Solicitation # SPE2DP-27-T-0125

Solicitation SPE2DP-27-T-0125 is a request for quotations from the Defense Logistics Agency for the procurement of activated charcoal suspension, identified by NSN 6505-01-282-8880. The requirement consists of five bottles, each with a volume of 240 ml and a weight of 50 grams. The items must be delivered to the USS Lewis B Puller ESB 3 by October 21, 2026, with a delivery lead time of 20 days. The product has a non-extendable shelf life of 36 months, and no more than five months may have elapsed from the date of manufacture to the date of delivery to the government. Storage must be maintained at a controlled room temperature between 20 and 25 degrees Celsius. Packaging must be commercial and include suitable sealed unit containers and exterior shipping containers to ensure safe delivery. Marking and labeling must adhere to Medical Marking Standard No. 1, superseding MIL-STD-129, and labels must include the NSN, manufacturer and CAGE code, date of manufacture, expiration or retest date, and the contract or lot number. The contract is governed by the DLA Master Solicitation for Automated Simplified Acquisitions Revision 105 and includes various FAR and DFARS clauses covering small business representations, hazardous material identification, and cybersecurity requirements. Inspection and acceptance will take place at the destination. Quotations are due by October 26, 2026, to the DLA Troop Support Medical Supply Chain Pharm FSA.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0123

Solicitation SPE2DP-27-T-0123 is a fixed-price request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Isoniazid Tablets, USP, 300 MG. The requirement consists of two CLINs totaling three bottles, with two bottles destined for the USS Lewis B Puller (ESB 3) and one bottle for the USS Kingsville (LCS 36). The items are identified by NSN 6505-00-132-6904 and must be provided in units of 100 tablets per bottle. Delivery is required within 20 days after receipt of order, with an original required delivery date of October 21, 2026, under FOB Destination terms. The drug is FDA regulated and must be stored at medical controlled room temperature with a non-extendable shelf life of 36 months. Packaging must adhere to MIL-STD-129 and Medical Marking Standard No. 1, with non-hazardous materials following ASTM D3951 and hazardous materials following TQ requirement IP025 and FED-STD-313. Palletization must comply with DLA requirement RP001. The contract incorporates various FAR and DFARS clauses, including those regarding the Buy American Act, Berry Amendment, and safeguarding covered defense information. Invoicing and receiving reports must be processed electronically through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

MOXIFLOXACIN HYDROCHLO

Solicitation # SPE2DP-27-T-0127

Solicitation SPE2DP-27-T-0127 is a fixed-price procurement by the Defense Logistics Agency for Moxifloxacin Hydrochloride Tablets, 400 MG. The requirement consists of three bottles, with each bottle containing 30 tablets. The product must be stored at controlled room temperature, avoiding high humidity, and is subject to a non-extendable shelf life of 36 months. Delivery is required within 20 days after receipt of order, with an original required delivery date of October 21, 2026. The shipment is designated as FOB Destination, with the final delivery point being the USS Lewis B Puller ESB 3. Compliance requirements include adherence to the DLA Master List of Technical and Quality Requirements, specifically RA001 and RP001 for packaging and procurement. Marking must follow the latest edition of Medical Marking Standard No. 1 and MIL-STD-129. Packaging must comply with ASTM D3951 for non-hazardous materials or TQ requirement IP025 for hazardous materials. The contract incorporates several federal regulations, including the Buy American and Balance of Payments Program, DFARS 252.204-7012 for safeguarding covered defense information, and NAICS code 325412. Invoicing and payment must be processed electronically through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 18 hours ago

DEADLINE

in 6 days

AI Contract Overview

This solicitation, identified as W911YU-25-Q-A025, is a combined synopsis and RFQ issued by the Department of the Army for the Immunization Supply FY2025 for the Medical Detachment of the Guam Army National Guard. It is set aside exclusively for small businesses under the SBA total small business set-aside category, with the procurement classified under NAICS code 325412 for Pharmaceutical Preparation Manufacturing, which has a size standard of 1,300 employees. The government has confirmed that funds are currently available for this effort, but retains the right to cancel the solicitation at any time prior to award without obligation to reimburse offerors for any costs incurred. The contract anticipated is a firm-fixed-price type, awarded through procedures outlined in FAR 16.202, with evaluation based on the Lowest Price Technically Acceptable (LPTA) criteria. Interested offerors are required to submit a signed Instructions to Offerors, a Price Proposal, and a Technical Proposal by the response deadline of July 10, 2025. The solicitation emphasizes that no other written solicitation will be issued, and all responses should adhere to the instructions provided. The contract will be administered by the W7QP Uspfo Activity Gu Arng office in Barrigada, Guam, with primary points of contact available via email and phone for further inquiries.

General Info

Solicitation for immunization supplies for Guam Army National Guard, small businesses only, FY2025.

Agency

Department Of Defense → W7QP Uspfo Activity Gu Arng

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

Barrigada, Guam, GU, 96913

Set-Aside

SBA

Documents

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed

PostedJul 7

Combined Synopsis

Response DeadlineJul 10

Deadline has passed

Submission Closed

07/10/2025, 03:00:00 AM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → W7QP Uspfo Activity Gu Arng

Contacts2 people available

OfficeBARRIGADA, GU, 96913, USA

Organization / AgencyDepartment Of Defense → W7QP Uspfo Activity Gu Arng

Office AddressBARRIGADA, GU, 96913, USA

Contacts

Austin Duenas

Maelani Ellison

Full Description

Update 0001: Government response to RFIs have been added. Please access the solicitation module in PIEE to view the document.Notice to Offeror(s): Funds are presently available for this effort. The Government reserves the right to cancel this solicitation, either before or after the closing date. In the event the Government cancels this solicitation, the Government has no obligation to reimburse an offeror for any costs. This is a combined synopsis/solicitation for commercial products or commercial services prepared in accordance with the format in Federal Acquisition Regulation (FAR) subpart 12.6, Streamlined Procedures for Evaluation and Solicitation for Commercial Products and Commercial Services, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotations are being requested and a written solicitation will not be issued. The solicitation number is W911YU-25-Q-A025. This solicitation is issued as a Request for Quotation (RFQ.) The solicitation document and incorporated provisions/clauses are those in effect through the Federal Acquisition Circular (FAC) 2025-04 (11 June 2025), and Defense Federal Acquisition Regulation Supplement Change 17 January 2025.A Small Business, Firm Fixed Price (FFP) contract is anticipated to be awarded to the business concern through the procedures of FAR subsection 16.202 Firm-fixed-price contracts. The quotations shall be evaluated based on Lowest Price Technically Acceptable (LPTA). The North American Industrial Classification System (NAICS) code for this procurement is NAICS 325412 Pharmaceutical Preparation Manufacturing, Size Standard 1,300 employees. Responders should include all documents and information requested submitted in accordance with the instructions herein. Required documents include: (1) Instructions to Offerors - SIGNED; (2) Price Proposal; and (3) Technical Proposal.

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 750+ contractors already using CLEATUS